Liner Outbreak Accelerates Unique Vaccine Development
World
The recent outbreak on the cruise liner MV Hondius has reminded the world of the cunning nature of the hantavirus—an infection for which no specific treatment exists. In response to this threat, an international team of scientists has launched a project to develop a next-generation vaccine. Thanks to an innovative storage technology, this drug is set to revolutionize medical delivery to the most remote corners of the globe.
An international team of specialists from the US and South Africa has begun developing a hantavirus vaccine using "silicification" technology. This method renders the vaccine resistant to temperature fluctuations, enabling its transport by drones to remote regions without the need for refrigeration equipment. The development became particularly urgent following infections and fatalities reported on the MV Hondius cruise ship in the Atlantic.
Hantaviruses are transmitted by rodents and attack the lungs and kidneys, often mimicking the flu. Currently, there is no specific therapy available, and early intervention is the only way to improve survival rates. Although the risk of a global pandemic remains low, scientists aim to create a robust protection tool to eliminate the threat of large-scale outbreaks in the future.
Hantaviruses are transmitted by rodents and attack the lungs and kidneys, often mimicking the flu. Currently, there is no specific therapy available, and early intervention is the only way to improve survival rates. Although the risk of a global pandemic remains low, scientists aim to create a robust protection tool to eliminate the threat of large-scale outbreaks in the future.
Powered by Froala Editor